Lewis H. Bender, Chief Executive Officer at INTERLEUKIN GENETICS INC (ILI), bought 3,000 shares at $1.40 ($4K) on 2008-02-19, disclosed to the SEC on 2008-02-20.
Open-market purchase of $4k ILI by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |